Two Sigma Securities’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Two Sigma Securities's IBB Position: Q1 2026 in Review
Two Sigma Securities sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 3,373 shares — an estimated $569K sold.
Two Sigma Securities first reported a position in IBB in Q1 2015 and held it in 28 quarters. The position peaked at $12.4M in Q1 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Two Sigma Securities reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 3,373 iShares Biotechnology ETF shares in Q1 2026, an estimated $569K.
- Two Sigma Securities first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 28 quarters.
- Two Sigma Securities's iShares Biotechnology ETF position peaked at $12.4M in Q1 2017.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.